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Deciphering the distance to 
antibiotic resistance for the 
pneumococcus using genome 
sequencing data
Fredrick M. Mobegi1,2,3, Amelieke J. H. Cremers1, Marien I. de Jonge1, Stephen D. Bentley4, 
Sacha A. F. T. van Hijum2 & Aldert Zomer1,2,5
Advances in genome sequencing technologies and genome-wide association studies (GWAS) have 
provided unprecedented insights into the molecular basis of microbial phenotypes and enabled the 
identification of the underlying genetic variants in real populations. However, utilization of genome 
sequencing in clinical phenotyping of bacteria is challenging due to the lack of reliable and accurate 
approaches. Here, we report a method for predicting microbial resistance patterns using genome 
sequencing data. We analyzed whole genome sequences of 1,680 Streptococcus pneumoniae isolates 
from four independent populations using GWAS and identified probable hotspots of genetic variation 
which correlate with phenotypes of resistance to essential classes of antibiotics. With the premise 
that accumulation of putative resistance-conferring SNPs, potentially in combination with specific 
resistance genes, precedes full resistance, we retrogressively surveyed the hotspot loci and quantified 
the number of SNPs and/or genes, which if accumulated would confer full resistance to an otherwise 
susceptible strain. We name this approach the ‘distance to resistance’. It can be used to identify the 
creep towards complete antibiotics resistance in bacteria using genome sequencing. This approach 
serves as a basis for the development of future sequencing-based methods for predicting resistance 
profiles of bacterial strains in hospital microbiology and public health settings.
Streptococcus pneumoniae, or the pneumococcus, is part of the normal bacterial flora of the human nasopharynx, 
but can occasionally infiltrate sterile sites of the body progressing to disease. An estimated 1.6 million deaths 
associated with S. pneumoniae are reported every year worldwide, mostly affecting children under five years. 
Despite the immunization efforts reducing pneumococcal disease, there is merely a marginal prospect of elimi-
nating pneumococcal disease because the available pneumococcal conjugate vaccines (PCV) only protect against 
13 of the over 97 circulating serotypes. Removal of vaccine-types also leads to rapid serotype replacement that 
consequently increases carriage prevalence and disease by non-vaccine serotypes with occasional increase in 
antibiotic resistance1.
Since the first case of penicillin-resistant pneumococcus was reported2, followed by outbreaks of disease 
caused by multidrug-resistant pneumococci3, the antibiotic resistance patterns of S. pneumoniae have dras-
tically evolved and escalated worldwide. The pneumococcus is known to be highly recombinogenic allowing 
sequences that confer antimicrobial non-susceptibility to be readily introduced into the genome. Discovery of 
the genetic determinants underlying microbial phenotypes such as antimicrobial resistance and virulence is an 
important question in microbiology. Traditionally, changes in DNA which are associated with antibiotic resist-
ance in S. pneumoniae were identified using sequence comparison, laboratory mutagenesis4, and identification 
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of horizontally transferred sequences5. These techniques are limited in specificity and sensitivity necessary for 
applications in clinical laboratories. They only reveal common genomic regions where change has occurred in 
the so-called ‘mosaic’ genes, are narrow in their application to study actual populations, and may miss out on sit-
uations where multiple mutations occurring in different genomic loci are required for full antibiotic resistance5,6. 
Significant advances in high-throughput genome sequencing technologies and bacterial genome-wide association 
studies (GWAS) now allow identification of statistical association between plausible causal genetic variants and 
microbial phenotypes in real populations7. This approach was recently used to identify the single nucleotide pol-
ymorphisms (SNPs) in DNA that may confer beta-lactam resistance in S. pneumoniae6.
However, understanding how genetic variations contribute to antibiotics resistance remains underexplored. 
Here we report the use of genome sequencing and GWAS to investigate SNPs and genes associated with resist-
ance to four essential classes of antibiotics; collectively referred to as antibiotic resistance hereafter. We name the 
cumulative effect of these resistance-conferring variants the “distance to resistance” for the pneumococcus. We 
analyzed 1,680 invasive and carriage pneumococcal isolates from Nijmegen, the Netherlands8, Massachusetts, 
USA9, Maela, Thailand6, and isolates from Sickle-cell anemic children (henceforth referred to as SCD; sickle cell 
disease) in the USA10. The genotypic and phenotypic diversity in these independent cohorts, whose draft genomes 
and phenotypes for antibiotic resistance are available, represent a unique dataset for identifying the contribution 
of each putative antibiotic resistance-conferring genetic variant to the pneumococcal resistance profile. With 
the premise that presence of particular genes or accumulation of specific SNPs precedes full drug resistance of a 
fit clone, whole genome sequencing and GWAS could be used to evaluate the rate of accumulation of candidate 
resistance-conferring variants and provide an early warning sign of increasing antibiotic resistance. We hypoth-
esize that the SNPs and/or resistance associated genes separating the phenotypes of antibiotic resistance are the 
plausible maximum number of mutations, which if accumulated could render high antibiotic resistance to oth-
erwise susceptible bacteria. As the clinics gradually embrace genome sequencing for microbiological analyses, 
the ability to use genomic sequencing data to predict relevant phenotypes such as antibiotic resistance will be 
essential and desirable. This study serves as a foundation for the development of future technologies that could 
utilize genomic sequencing to analyze the molecular epidemiological trends for bacterial strains reliably, and 
provide an early-warning measure for the edge towards antimicrobial resistance, crucially informing on clinical 
intervention strategies.
Results
Pneumococcal strains and phenotypes of antibiotic resistance. We analyzed 1,680 disease and car-
riage S. pneumoniae isolates systematically selected from diverse cohorts (see materials and methods). In carriage 
isolates from Maela and Massachusetts, 54 of the 1,012 were resistant to trimethoprim, penicillin, erythromycin 
and cotrimoxazole, representing about 0.054% resistance to four classes of essential antibiotics (multidrug resist-
ance; MDR). Additionally, all 263 carriage isolates that showed full resistance to penicillin were also resistant to at 
least one other antibiotic of a different class (~26% resistance to penicillin and one other antibiotic). In contrast, 
only one isolate from Nijmegen (10208_2#41) showed resistance to all antibiotics tested. Three isolates from 
Nijmegen exhibited resistance to penicillin (Fig. 1; Supplementary Table S1).
Overall, the Nijmegen cohort had the lowest percentage proportion of isolates showing antibiotic resist-
ance; penicillin 0.86% (3 isolates), trimethoprim 4.29% (15), erythromycin 2.28% (8), and cotrimoxazole 4.29% 
(15), as compared to the selection of Maela and Massachusetts isolates; penicillin 25.99% (263), trimethoprim 
14.13% (143 isolates), erythromycin 35.57% (360), and cotrimoxazole 27.76% (281). However, the proportions of 
resistance to fluoroquinolones; ciprofloxacin 22.86% (80) and ofloxacin 50% (175) were remarkably high in the 
Nijmegen IPD isolates.
Specific polymorphisms and genes showing significant association with antibiotic resistance. 
Candidate putative causal variants were selected as SNPs showing statistically significant associations with the 
resistance phenotype (p-values < 0.01, stratified for population substructure and Bonferroni-adjusted for multiple 
testing). Separate associations were tested for resistance to penicillin, trimethoprim, cotrimoxazole, erythromy-
cin, ciprofloxacin, and ofloxacin. We identified, 4,317 SNPs that confer resistance to penicillin, 3,589 in coding or 
intragenic sequences and 548 in non-coding or intergenic sequences (Fig. 2; Supplementary Table S2). A q-q plot 
of the penicillin GWAS p-values showed a sharp deviation above an expected p-value indicating the presence of 
unusually high linkage disequilibrium (LD) and strong association of the phenotype with SNPs in heavily geno-
typed loci. To further control for inflation and increase confidence in verity, a more stringent p-value threshold 
cut-off was applied at the point of deviation of the observed p-values from the expected p-values. This new cut-off 
(p-value < 1.5E-20) produced a smaller subset of 426 SNPs associating to the penicillin resistance phenotype. 
The SNPs are localized primarily in genes previously reported to be involved in development of penicillin resist-
ance, including genes involved in the peptidoglycan biosynthesis pathway such as penicillin binding proteins; 
PBPs (pbp1A, pbp1B, pbpX, pbp2A, penA), peptidoglycan biogenesis transferases (mraW, mraY) and synthesis of 
peptidoglycan precursors (murM, murN), pneumococcal surface proteins (pspA, pspC), recombination pathway 
(recU), cell division pathway (gpsB, ftsL), multi-drug resistance (MDR) proteins and drug efflux pumps (pmrA), 
drug antiporters6, heat shock proteins/chaperones (ClpL)11, and genes implicated in resistance to other essential 
classes of antibiotics like dihydrofolate reductase (dyr); involved in trimethoprim resistance12,13.
We employed a machine learning method, Random Forest (RF), to investigate the combinatorial effect of 
certain SNPs and or/genes and prioritize causal variants. From the 426 SNPs, the RF model identified 34 unique 
SNPs that are predictive of penicillin resistance (Table 1). A separate GWAS on the presence or absence of indi-
vidual genes in each isolate also revealed that presence of variants of the cell division initiation protein, gpsB 
(og_2891 and og_1645; p-values 4.73E-44 and 4.06E-43 respectively; Bonferroni-adjusted for multiple test-
ing) significantly correlates with penicillin resistance. Combining both the SNPs and the genes (represented by 
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orthologous groups; OGs) in a RF model further determined that the gene gpsB (og_2891 and og_1645) is the 
only gene among the top 20 features (SNPS and genes) that are predictive of penicillin resistance.
Penicillin-resistant pneumococcus exhibit varying patterns of resistance to other β -lactams and are generally 
resistant to other classes of antibiotics that are usually active against pneumococci14. We evaluated resistance to 
trimethoprim and cotrimoxazole, erythromycin, as well as ofloxacin and ciprofloxacin. We identified SNPs asso-
ciated with resistance to trimethoprim and cotrimoxazole in various genes encoding enzymes involved in folate 
metabolism, including dyr, folE, and folP (Fig. 2; Supplementary Tables S3–S4), and SNPs in genes implicated in 
resistance to other essential antibiotics like penicillin. RF analysis revealed that only mutations in genes involved 
in folate metabolism (dyr, folC, folE, folP, and 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine diphos-
phokinase; HPPK (EC 2.7.6.3) encoded by folK or sulD), and chaperones/ATP-dependent proteases (clpL, clpX)15, as 
well as linked mutations in PBPs (pbp1A, pbpX, penA), recombination proteins (recR, recU), and peptidoglycan bio-
genesis transferases (mraW, mraY), were predictive of cotrimoxazole and trimethoprim resistance (Tables 2 and 3).
Target site modification, characterized by presence of the ermB gene, and efflux from bacteria, mediated by 
the product of the mefA gene, are the most common mechanisms of bacterial resistance to macrolides. Before 
correcting for multiple testing, we observed a statistically significant association between the presence of ermB 
(og_1123) and resistance to erythromycin (p-value 3.137E-05). The OG comprises of two variants of the 23S 
rRNA (adenine [2058]-N6-)-methyltransferase (ermB): one variant is of the Staphylococcus aureus origin 
(ungapped protein blast - blastp - alignment with 100% sequence identity over 100% sequence coverage and 
an e-value of 3e-176). Surprisingly, this association significance diminishes after correcting for multiple testing 
(p-value 0.09; Bonferroni-corrected for multiple testing). Even so, we identified SNPs in the 16S rRNA; rsmE, 50S 
rRNA; rplM/S/B/T, rpmA/E2/F/H, rplE/L/I, and 30S rRNA; rpsA/M/N/P/D/H molecules that significantly asso-
ciated with erythromycin resistance (Fig. 2; Supplementary Table S5). In the RF analysis, the presence of various 
genes was associated with resistance to erythromycin (Table 4). They include the macrolide efflux pump mefA 
(og_1312); ImpB/MucB/SamB family protein (og_1652): a family of error-prone DNA polymerases involved in 
DNA repair; the YolD-like protein (og_1379), a group of functionally uncharacterized proteins predicted to be 
functionally alike to the UmuD subunit of polymerase V from Gram-negative bacteria, and the ribose import 
ATP-binding protein (og_791; SP_1114).
Resistance in S. pneumoniae to fluoroquinolone is caused predominantly by mutations in DNA gyrase (gyrA) 
or DNA topoisomerase (parC and occasionally parE), which reduces binding of the drug to the site of activity. 
We did not observe any associations between SNPs in fluoroquinolone target proteins (DNA topoisomerase and 
Figure 1. A maximum likelihood phylogeny of the concatenated variant regions from the core genome 
of 1682 pneumococcal isolates. The clades are colored according to the sequence clusters. The circular 
stripes represent the antibiotic resistance phenotypes starting from the outermost: pink; penicillin, green; 
erythromycin, blue; trimethoprim, gold; cotrimoxazole, navy-blue; ciprofloxacin, and purple; ofloxacin.
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Figure 2. Manhattan plots summarizing the statistical significance of genome-wide associations between 
whole-genome SNPs and resistance to various antibiotics. Specific loci that are significantly associated with 
resistance to antibiotic are shown in the top panel.
BP Position RF importance RF p-value CMH p-value Annotation Gene
1613086 20.62957785 0 3.308E-99 penicillin-binding protein 2b penA
1612897 19.83961807 0 6.649E-85 penicillin-binding protein 2b penA
333792 11.86365577 8.69E-98 1.234E-99 Holliday junction-specific endonuclease recU
333282 11.70867819 1.55E-18 5.304E-55 penicillin-binding protein 1 A pbp1A
334107 11.29654702 7.83E-162 9.151E-72 Holliday junction-specific endonuclease recU
334639 10.42365322 0 1.203E-68 hypothetical protein —
294991 10.24670847 0 5.276E-60 phospho-N-acetylmuramoyl-pentapeptide-transferase mraY
335104 8.53526957 3.3E-17 2.659E-68 DivIVA protein —
333345 7.379638353 6.46E-16 8.607E-24 penicillin-binding protein 1 A pbp1A
1613422 7.320298527 9.51E-56 4.344E-55 penicillin-binding protein 2b penA
292563 7.167180495 8.14E-08 1.294E-55 penicillin binding protein 2x pbpX
332247 6.771832321 4.27E-26 3.671E-55 penicillin-binding protein 1 A pbp1A
335955 6.631966798 8.25E-35 9.742E-45 RNA methylase family protein —
1613770 6.108715366 7.27E-87 2.023E-78 penicillin-binding protein 2b penA
333386 5.891738108 4.68E-13 8.607E-24 penicillin-binding protein 1 A pbp1A
1532326 5.159428663 2.95E-11 4.143E-72 dihydrofolate reductase dyr
1531915 5.154251817 1.21E-11 1.717E-20 ATP-dependent protease ATP-binding subunit ClpX clpX
295737 4.619274035 1.67E-75 7.271E-49 ATP-dependent protease ATP-binding subunit ClpL clpL
296748 4.473732826 4.15E-08 2.701E-36 ATP-dependent protease ATP-binding subunit ClpL clpL
2193975 4.432372852 3.41E-61 8.905E-27 elongation factor Ts tsf
Table 1.  Single nucleotide polymorphisms that are associated with penicillin resistance.
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DNA gyrase) and fluoroquinolone resistance (Supplementary Table S5). Nonetheless, we observed a statistically 
significant association between mutations in a multi-drug resistance efflux pump (pmrA) and resistance to oflox-
acin (p-value 5.06E-05). We also observed that mutations in the heme exporter protein A (ccmA) and the recom-
bination factor protein (rarA) associated with resistance to the fluoroquinolone ciprofloxacin.
Predicting antibiotic resistance profiles and the prospective value of the ‘distance to resistance’. 
With a presupposition that accumulation of particular SNPs, or acquisition of certain genes leads to a creep 
towards antibiotic resistance and subsequently full-resistance, we sought to categorize the strains according to 
their phenotype of antibiotic resistance using the putative resistance-conferring SNPs and/or genes identified by a 
GWAS. We identified the partition between isolates by summing up the logarithmic derivatives of the odds ratios 
(sOR) for the putative antibiotic resistance-conferring SNPs (Fig. 3).
Feature RF importance RF p-value CMH p-value Annotation Gene
1531915 12.06447624 0 3.65E-32 ATP-dependent protease ATP-binding subunit ClpX clpX
293661 10.58122979 2.05E-112 1.3E-75 penicillin binding protein 2x pbpX
267233 10.09698603 0 5.656E-82 GTP cyclohydrolase I folE
1532245 9.521815356 0 2.616E-81 dihydrofolate reductase dyr
1613086 9.414234472 5.99E-237 8.051E-62 penicillin-binding protein 2b penA
264912 8.905643954 0 1.032E-75 dihydropteroate synthase folP
1531651 7.923116586 0 4.595E-60 ATP-dependent protease ATP-binding subunit ClpX clpX
265536 7.247622768 5.56E-86 3.638E-67 dihydropteroate synthase folP
291557 6.341493841 3.03E-43 3.097E-61 cell division protein ftsL
292017 5.849575748 7.35E-31 4.103E-50 penicillin binding protein 2x pbpX
1532054 5.822732316 0 1.203E-28 hypothetical protein —
1612897 5.726042635 8.3E-102 1.213E-49 penicillin-binding protein 2b penA
262352 5.671693703 0 1.208E-38 — —
263885 5.610620269 9.89E-132 7.608E-41 permease —
332799 5.455168203 5.73E-56 1.758E-48 penicillin-binding protein 1A pbp1A
262539 5.429029061 0 2.304E-33 — —
263190 5.333550128 9.15E-144 4.673E-26 permease —
1613770 5.331345531 3.4E-65 2.497E-51 penicillin-binding protein 2b penA
291982 5.096429153 4.18E-34 3.797E-47 penicillin binding protein 2x pbpX
335104 4.434933551 0.000000165 1.249E-40 DivIVA protein —
Table 2.  Single nucleotide polymorphisms and genes that correlate with cotrimoxazole resistance.
Feature RF p-value CMH p-value Annotation Gene
267970 4.39E-262 2.51E-13 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase —
291557 4.19E-57 6.03E-15 Cell division protein ftsL
292017 4.99E-52 2.89E-16 Penicillin binding protein 2x pbpX
291982 9.37E-47 1.34E-16 Penicillin binding protein 2x pbpX
cog_1652 3.01E-198 3.54E-08 ImpB/MucB/SamB family protein —
cog_1312 1.79E-58 0.00000173 Macrolide efflux pump —
cog_1379 4.39E-85 0.000000119 YolD-like protein —
cog_791 3.88E-48 0.00000049 Ribose import ATP-binding protein rbsA —
cog_2061 1.41E-90 0.000000119 Hypothetical protein —
291286 3.39E-15 7.68E-17 S-adenosyl-methyltransferase MraW mraW
290545 3.38E-26 6.7E-12 — —
1558235 4.29E-19 4.69E-11 Cytidylate kinase cmk
cog_1645 0 0.001967 Cell division initiation protein —
cog_2891 0 0.000622 Cell division initiation protein —
cog_182 1.49E-25 0.001306 Binding-protein-dependent transport systems inner membrane component —
2002234 2.83E-28 6.6E-15 PTS system ascorbate-specific transporter subunit IIC —
1459029 5.58E-30 4.56E-12 Asparaginyl-tRNA synthetase asnC
887794 1.4E-27 4.56E-12 DNA polymerase III subunit epsilon —
1800425 0.0000387 1.73E-21 DegT/DnrJ/EryC1/StrS family amino sugar synthetase —
Table 3.  Single nucleotide polymorphisms and genes that correlate with trimethoprim resistance.
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In response to environmental stress over time, bacteria evolve genetic adaptations such as the acquisition of 
resistance genes or accumulation of critical mutation that confer antibiotic resistance. Supplementary Figure 1 
shows the resistance profiles for four antibiotics over time in different cohorts. There seems to be an increase, 
however subtle, in the number of isolates that have accumulated more resistance-conferring SNPs in each cohort 
every year. The IPD isolates from Nijmegen have particularly accumulated combinations of SNPs that confer 
resistance but are more close to susceptibility as compared to carriage isolates. From this data, it is possible to 
model the resistance profile of new clinical isolates and to predict strains that are approaching extreme antibiotic 
resistance using sequencing-based approach. Using the RF analysis, we observed that carriage (non-invasive) 
strains exhibited more resistance to antibiotics (through accumulating SNPs acquiring genes that are most likely 
to) than invasive strains (Fig. 4). They mostly contained resistance-associated SNPs with high odds ratios of 
conferring resistance. We also observed that increase in minimum inhibitory concentrations (MIC) against peni-
cillin is characterized by an increase in high sORs SNPs are prioritized by the RF model (Fig. 5). Additionally, we 
observed that the antibiotics-susceptible isolates (MIC < 0.016 μ g/ml) have also acquired some level of mutations 
that bring them closer to low-MIC penicillin resistance, which in clinical practice can be managed by increased 
penicillin dose.
Discussion
This study includes a total of 1,680 S. pneumoniae isolates from diverse cohorts. Of these, a total of 1,012 carriage 
isolates (Massachusetts and Maela), and 350 IPD isolates (Nijmegen) were included in a GWAS to pre-screening 
for resistance-conferring variants. Another 318 SCD isolates were later included in the post-association eval-
uation of SNPs to determine the distance to resistance. Compared to the general population, SCD patients are 
usually at high risk of contracting potentially fatal IPD. Therefore, they receive long-term antibiotic prophylaxis 
and frequent empiric antibiotic treatment. In response to the antibiotic selective pressure, pneumococci isolated 
from SCD patients have been shown to exhibit high rates of antibiotic resistance10. As a result, isolates from these 
patients were expected to exhibit substantial resistance that could skew the statistical associations.
Antibiotic resistance profiles differed significantly between sampled populations, and between invasive and 
nasopharyngeal carriage isolates. Rates of antibiotic resistance were generally low in isolates from the Netherlands 
compared to those from Thailand and USA. The low levels of resistance in the Netherlands could be explained 
by two reasons. First, all Dutch isolates used in this study are from IPD cases whereas the Thai and US isolates 
are predominantly carriage isolates. There is ample opportunity for pneumococci in carriage to benefit from 
multiple co-colonizing strains of same or closely related species that provide new genetic material for homol-
ogous gene transformation. Rates of pneumococcal transformation are also much higher during colonization 
than during planktonic growth in sepsis16. Second, the Netherlands has implemented very stringent antibiotic 
control policies. The WHO provides defined daily dose (DDD) guidelines for antibiotics use in adults. Research 
has shown that aggregate hospital antibiotic use by DDD in the United States is discordant with the WHO stipu-
lations17. Most studies established that majority of antibiotics were administered in primary care settings to treat 
infections for which antibiotic therapy is hardly indicated18,19. Similarly in Thailand, antibiotics are readily sold 
over-the-counter allowing for endemic misuse20. Such trends are likely to have accelerated the pneumococcal 
Feature
RF 
importance RF p-value CMH p-value Annotation Gene
og_1652 7.180656298 0 3.701E-14 ImpB/MucB/SamB family protein —
og_1379 7.175992284 0 6.409E-15 YolD-like protein —
og_2061 7.097377018 0 6.409E-15 hypothetical protein —
og_1312 6.485953794 1.71E-217 2.683E-14 Macrolide efflux pump mefA
og_791 6.017699918 1.03E-210 6.671E-14 Ribose import ATP-binding protein rbsA —
1741683 4.904707263 8.7E-52 3.01E-23 Nudix-related transcriptional regulator NrtR —
og_243 4.114250972 0.00000718 0.0002367 IS1380-Spn1 transposase —
og_10 3.24238261 0.000118 0.01343 3-ketoacyl-ACP reductase —
290545 3.240769624 1.2E-76 6.7E-12 Tn916 ORF16 ATP/GTP-binding protein —
297653 3.016787219 4.01E-28 2.24E-16 methyltransferase small domain superfamily —
og_53 2.971456253 5.89E-142 4.8E-09 UDP-glucose 6-dehydrogenase —
og_129 2.962230108 0.000564 4.443E-07 chlorohydrolase —
678325 2.695815692 1.6E-53 2.15E-15 transposase, ISSmi4 —
136082 2.412872116 2.23E-15 7.73E-14 cytidine deaminase cdd
637379 2.41015196 6.07E-44 1.36E-10 nucleotidyl transferase WchZ —
987093 2.253968194 7.1E-12 4.43E-23 Abi-alpha protein —
2058103 1.964208468 8.09E-10 5.51E-18 transposase —
og_4190 1.95393053 0.385 0.4235 IS630-Spn1, transposase Orf1 —
1593956 1.93060019 8.68E-09 1.62E-10 Ribose import ATP-binding protein rbsA —
794795 1.754564135 0.000000235 1.62E-10 hypothetical protein —
Table 4.  Single nucleotide polymorphisms and genes whose presence correlates with erythromycin resistance.
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selection for resistance in the US and Thai populations, and could explain the observed higher levels of resistance 
as compared to, for example, the Dutch population where antibiotic use is vastly prudent.
Penicillin and other β -lactams have for long been the primary means of treating pneumococcal infections and 
are perhaps the most widely used group of antibiotics that work by inhibiting bacterial cell wall biosynthesis21. 
Resistance arises when the organism produces beta-lactamases, which are enzymes that cleave the beta-lactam 
ring, or modifies the drug targets; ‘penicillin binding proteins’; PBPs. Published research implicates changes 
in PBPs as the primary determinants of β -lactams resistance22–24. Variations in PBP2b and PBP2x modulate 
low-level (intermediate) β -lactams resistance with additional changes in PBP1a leading to extreme resistance. 
Growth inhibition assays show that β -lactams primarily kill the pneumococcus by inhibiting PBPs, particularly 
PBP2× 25. PBP transpeptidase signatures are also significant indicators of resistance levels in various β -lactams26.
Figure 3. Penicillin, erythromycin, trimethoprim, and cotrimoxazole resistance profiles for isolates 
from individual geographical locations. Each point represents the cumulative odds ratio effect of SNPs that 
significantly associate with resistance on each isolate.
www.nature.com/scientificreports/
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SNPs associated with beta-lactam resistance were previously reported using GWAS6. We identified 4,317 
penicillin-resistance associated SNPs in the pneumococcus, which is more than Chewapreecha and colleagues 
observed (858 and 1,721 in Maela and Massachusetts cohorts respectively - 301 common SNPs). The difference 
could be explained by the fact that Chewapreecha et al. replicated their statistical associations in two independent 
cohorts and only collated candidate SNPs that were identified to be common between the two groups. In contrast, 
we selected all SNPs showing significant statistical association (p-value < 0.01) with the phenotype after correct-
ing for multiple testing. Moreover, we potentially introduced more genotypic variance by analyzing a mixture 
of isolates, especially the disease isolates, from different geographical areas. The divergent genotypes in practice 
resulted into more sequence clusters (used for population substructure stratification) further partitioning the 
Figure 4. The difference in resistance profiles between invasive and carriage isolates. Each point represent 
the cumulative random forest vote for invasive (triangles) and carriage (circles) isolates.
Figure 5. (A) A box whisker plot of the random forest votes for the levels of resistance to penicillin. Increase 
in resistance (MIC >= 0.06 µg/ml), as measured by relative increase in the MIC per isolate, is coupled with 
increased accumulation of the resistance-conferring SNPs that in turn uplift the votes. (B) A Receiver Operating 
Characteristic (ROC) curve showing the discrimination power of this random forest model in predicting 
penicillin resistance (Area Under Curve; AUC min = 0.9417 and max = 0.9882 at 99.9% CI).
www.nature.com/scientificreports/
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phylogenetic clusters/clades that may have been considered similar in the Chewapreecha study. Therefore, our 
approach allowed for identification of more SNPs. Applying a more stringent p-value threshold, however, reduced 
the number of SNPs allowing for further prioritization using RF. The onset of these SNPs is perhaps indicative of 
the development of antibiotic resistance. However, more studies will be required to validate these observations.
In the case of penicillin resistance, a single SNP or gene is not enough to confer full resistance. We used the RF 
analysis to evaluate the contribution of combinations of SNPs and/or genes to resistance to penicillin. The mixed 
RF model incorporating SNPs and genes showed that resistance to β -lactams is primarily driven by mutations in 
key genes and possibly by the presence of certain resistance genes. In this model, only the gpsB gene was among 
the top penicillin-resistance conferring features. GpsB is thought to be putatively essential27 and thus expected 
to be present in a single copy in all isolates. however, there appears to be two variants of the gpsB gene, og_1645; 
n = 1457 and og_2891; n = 215 in our isolates. GpsB is vital for peripheral and septal peptidoglycan synthesis in 
S. pneumoniae, particularly in the recruitment of PBP1 to the division complex and its removal from the cell pole 
soon after pole maturation is completed27. It shows overlapping although non-identical pattern of co-localization 
with FtsZ during cell division. Depletion of gpsB causes division defect characterized by significant cell elongation 
and enlargement, several unconstricted rings of division proteins Pbp2x, Pbp1a, FtsZ, and MreC, cessation of 
growth, and eventually cell lysis in S. pneumoniae D3927. These phenotypes are similar to those observed in Pbp2x 
depletion28 or inhibition of Pbp2x by the β -lactam antibiotic methicillin27. Therefore, the observed association 
is most likely a secondary effect of the functions of gpsB in peptidoglycan synthesis during cell division which 
may have fitness and pleiotropic consequences in maintaining cell integrity rather than a direct role in resistance.
Trimethoprim and cotrimoxazole (a combination of trimethoprim and sulfamethoxazole) reduce the ability of 
some bacteria to utilize folic acid for growing12 by blocking folate metabolism via dhfR or dyr (encoding dihydro-
folate reductase), and folP/sulA (encoding dihydropteroate synthase) respectively. Although there is increasing 
prevalence of resistance of S. pneumoniae to these drugs, they are still deemed as excellent treatment particularly 
for pneumococcal infection as well as more generally for otitis, sinusitis, and acute exacerbation of chronic bron-
chitis. Mutational or recombinational changes on the target enzymes; dhfR and folP or their promoter regions 
have been reported to enhance resistance to trimethoprim and cotrimoxazole12,13,29. As expected, SNPs in various 
genes of the folate metabolism pathway correlated with resistance to trimethoprim and co-trimoxazole. Other 
significant associations for SNPs in genes implicated in resistance to other essential antibiotics, for example PBPs 
(pbp1A, pbpX, penA) implicated in penicillin resistance, indicating a strong co-selection for resistance to different 
classes of antibiotics by the pneumococcus. This could be due to the frequent simultaneous use of these antibiotics 
or an epistatic effect of linked compensatory pathways. More studies will be required to validate this observation.
Macrolides remain an important class of antibiotics for pneumococcal disease30. They inhibit protein synthesis 
by penetrating the bacterial cell membrane and binding to the ribosomal RNA molecules, particularly in the 50S 
subunit, of the bacterial ribosome blocking the exit of the growing peptide chain. Their prevalent use in other 
indications may be the primary driver of selection for macrolide resistance in pneumococci31–33. Pneumococcal 
resistance to macrolides is caused by drug efflux or alteration of the target site34,35. The phenotypic expression of 
target-site modification can be inducible or constitutive, and can be confirmed with the presence of mefA/E and 
ermB genes. MefA and mefE share > 90% sequence homology and are carried in transposons which are comprised 
of additional open reading frames36. Perhaps due to the low prevalence of ermB (n = 124), the significance of sta-
tistical association waned after adjusting for multiple testing. Nonetheless, presence of other proteins like ImpB, 
YolD-like protein, SP_1114, and the macrolide efflux pump (encoded by mefA) was determining of resistance to 
erythromycin. The functional protein interaction network STRING shows that SP_1114 directly interacts with 
various efflux pumps associated with antibiotic resistance: the drug efflux ABC transporter ATP-binding protein/
permease (SP_1342), the MATE efflux pump (SP2065), and the MATE family DinF transport system (SP1939)37, 
which may suggest a possible contribution to the efflux of drug. This may, however, need more studies to substan-
tiate. YolD-like proteins, like their presumed equivalent (UmuD) in Gram-negative bacteria38, could be involved 
in modifying the DNA replication machinery to allow bypass synthesis across a damaged template. ImpB on the 
other hand copies undamaged DNA at stalled replication forks which arise in vivo from mismatched or mis-
aligned primer ends. These misaligned primers could be extended by DNA polymerase IV subunit (polIV). The 
important role of these proteins in division and maintaining cellular integrity may perhaps explain their indirectly 
contribution to erythromycin resistance.
Fluoroquinolones (Ofloxacin and ciprofloxacin) are a family of related compounds that inhibit bacterial DNA 
synthesis by promoting cleavage of DNA in the DNA-enzyme complexes of DNA gyrase and type IV topoi-
somerase. Ciprofloxacin binds exclusively with topoisomerase IV whereas ofloxacin binds more avidly with 
topoisomerase IV and also binds the gyrase. Fluoroquinolone activity in Gram-positive bacteria, including S. 
pneumoniae, usually results from inhibition of DNA type IV topoisomerase whereas activity in Gram-negative 
bacteria corresponds with inhibition of DNA gyrase. Pneumococcal resistance to fluoroquinolone is thought 
to be a stepwise process; most intermediately resistant strains accumulate first-step mutations, which usually 
involve only a single mutation in the target genes39, although, these strains do tend to go on to develop subse-
quent second-step mutations which significantly diminishes the activity of most fluoroquinolones and renders 
the strains highly resistant40. This increasing mutational heterogeneity makes it harder to use GWAS in precisely 
identifying the role of each mutation in disseminating antibiotic resistance to fluoroquinolones. While there 
were no significant associations for mutations in the target proteins, mutations in other genes like pmrA, ccmA, 
and rarA were observed to be determining of resistance to fluoroquinolones. Mutations in correlated with resist-
ance to ofloxacin. PmrA is homologous to other well-studied efflux pumps like NorA and Bmr, whose expres-
sion leads to reduced susceptibility against several diverse compounds41, and is associated with fluoroquinolone 
resistance in the pneumococcus42. The pneumococcus, like most pathogenic bacteria, mainly uses iron from 
hemoglobin and heme to support growth43. The direct role of CcmA in quinolone-resistance is unclear but in 
Group A streptococci (GAS), the heme exporter confers multi-drug resistance44. Apart from the ABC-transporter 
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protein PmrA42, efflux mechanisms of fluoroquinolone resistance are poorly characterized in the pneumococ-
cus. Nonetheless, efflux could reduce intracellular fluoroquinolone concentrations to sublethal levels facilitating 
resistance development45. More experiments are required to deduce the exact mechanisms involving these other 
efflux pumps.
Recombination is the primary source of genome plasticity in bacteria. Unlike in β -lactam resist-
ance where recombination plays an important role46, fluoroquinolone resistance arises from very specific 
resistance-determining mutations within the target proteins47. Horizontal transfer of fluoroquinolone resist-
ance loci between viridans group streptococci and the pneumococcus has been shown to occur in vitro but not 
in vivo48, with significantly higher rates during asymptomatic carriage than during invasive isolates49,50. Studies 
have reported a link between fluoroquinolone resistance and evolution of resistance to penicillin and mac-
rolides51; both of which could be fostered by recombination. These studies suggest that the observed association 
between ciprofloxacin resistance and mutations in rarA could be an artifact of the linked resistance with other 
antibiotics. However, since we cannot rule out a novel mechanism involving these mutations, more studies are 
required to ascertain this observation.
Pneumococci exhibiting decreased susceptibility to regular penicillin doses are on the rise14. Many European 
guidelines recommend high-dose empirical treatments for systemic infections caused by such strains showing 
atypical susceptibility. Analyzing the strains for an effective dose, however, relies on laboratory assays. A recent 
publication reports the use of PBPs transpeptidase signatures (TPDs) from 2,528 clinical pneumococcal isolates 
to predict the MICs for various β -lactam antibiotics26. Li and colleagues constructed predictive models that link 
amino acid sequence variations in the TPDs of PBP1a, PBP2b, and PBP2x to β -lactam MIC levels among invasive 
pneumococcal isolates. They identified 68, 78, and 118 unique TPD amino acid sequences for PBP1a, PBP2b, 
and PBP2x, respectively. Using 307 unique combinations of these sequences which defined the PBP types, they 
observed that isolates whose PBP types exhibited more than 10% amino acid sequence divergence from a usual 
susceptible PBP type were associated with increased β -lactam MICs.
Using GWAS and RF, we have rapidly detected decreasing sensitivity of the pneumococcus to increasing doses 
of penicillin, and we have classified susceptible and resistant isolate using genome sequencing with the sensitivity 
and specificity comparable to the MICs determined using phenotypic susceptibility tests. The increase in MIC 
corresponded with accumulation of SNPs and acquisition of genes that we prioritized to be most determining of 
penicillin resistance. Moreover, we have determined how far the antibiotic susceptible strains are from acquir-
ing the resistance-conferring features that will enable them attaining full-resistance, and what the creep pattern 
towards full-resistance is. The measure is dubbed the “distance to resistance”. Starting with a curated reference 
database of genes and SNPs/alleles that confer resistance in historical and contemporary isolates; it is possible to 
model a framework that predicts the antibiotic resistance profile of an isolate, and project the transition towards 
resistance over time. Although causality cannot always be drawn from statistical association, bacterial GWAS 
provide the means for identifying genomic variants underlying important microbial phenotypes like antibiotic 
resistance. We have demonstrated that prediction of advancing antimicrobial resistance could be achieved in silico 
using genomic sequencing data. Therefore, this study invokes a change of perspective for future research to focus 
on not only identify genetic variants underlying the resistance phenotype but also detecting how these variants 
herald the advancement towards full-resistance. Such sequencing-based frameworks are not only affordable and 
consistent but also allow for simultaneous discovery of other essential pneumococcal features such as serotype 
and sequence type. Altogether, this knowledge will greatly inform the choice of clinical intervention and improve 
public health surveillance thus precluding outbreaks caused by emerging multidrug resistant strains.
Materials and Methods
Strains and phenotypes in study. This study included 1,680 pneumococcal isolates and corresponding 
antibiotic resistance phenotypes; 349 from adults admitted with invasive pneumococcal disease between 2001 
and 2011 in two hospitals in Nijmegen, The Netherlands8, a systematic selection (three from each “secondary 
BAPS” cluster) of published carriage isolates from Massachusetts, USA and Maela, Thailand6, and 318 isolates 
from children suffering from sickle-cell disease (SCD) in the USA10 which included isolates from the CDC ABC 
bacterial surveillance core and published collections52,53. Phenotypes of antimicrobial susceptibility were deter-
mined in vitro as previously described6,8,9. For the invasive Nijmegen isolates, the following breakpoints were 
used: penicillin susceptible (S) = < 00.6; co-trimoxazole S = < 1; erythromycin S = < 0.25.
Determining SNPs and orthologous sequences. Bases were called from mapped sequences using 
kSNP v2 software54 against a single reference genome: multidrug-resistant S. pneumoniae ATCC 700669; Spain 
23F ST8155. A total of 124,310 SNP calls were generated (Numerical feature IDs used in this study correspond 
to the SNP base-pair position in this reference genome). Filtering for SNPs present in more than ~90% of the 
isolates, (1,500 strains) resulted in 76,429 SNP calls that we used for further analysis. To determine clusters of 
orthologous sequences, all coding sequences (CDS) from the 1,680 isolates were predicted using Prodigal56. All 
coding sequences were analyzed using USEARCH57 and aligned in the ‘large-scale BLAST score ratio’ (LS-BSR) 
pipeline58 allowing 10% amino acid difference within clusters. The resulting representative sequences per group 
(“centroids”) were clustered through a Markov Clustering Algorithm (TRIBE-MCL)59 with an inflation factor of 
2.5, resulting into 4687 orthologous groups (OGs). For each OG, we generated a binary metric of the presence (1) 
or absence (0) of a representative coding sequence(s) (CDS) from each strain. Each strain’s contribution of CDS 
to an OG was subsequently denoted by a single numeric value (1 or 0) to designate the presence or absence of a 
distinct gene, gene variants, or a group of paralogs. These groups were collated into a binary matrix and formatted 
for PLINK association analyses60.
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Determining the population structure and statistical association. Resistance phenotypes were 
grouped according to antibiotic classes and analyzed separately for each population, and together in the final 
association analysis. The population clusters used to control for the effect of clonal inheritance of genetic vari-
ants and population stratification were determined using the Bayesian Analysis of Population Structure (BAPS) 
software61, and a phylogeny-based partitioning approach as proposed by Prosperi et al.62, which employs ‘ape, 
geiger, igraph, and phytools’ packages in R software63. An alignment of concatenated SNPs from the core or 
non-repetitive DNA of each of the isolates were analyzed in BAPS as previously described8. For the Prosperi clus-
tering, a maximum-likelihood phylogenetic tree was constructed using RAxML version 8.2.064 and an alignment 
of all the concatenated SNPs from the core genome of all isolates as described before8. The general time-reversible 
model was used to calculate the maximum-likelihood ratios with a γ adjustment for site variation as the nucle-
otide substitution model. The support for nodes on the tree was tested using a hundred unsystematic bootstrap 
replicates. Resulting phylogenetic tree was visualized using iTOL version 2.165.
We used the Cochran-Mantel-Haenszel (CMH) correlation statistic to test for associations between antibiotic 
resistance phenotype and SNPs conditional on the population structure. Stratification for population structure 
minimized falsely positive associations that could be obtained merely by chance. We tested associations for resist-
ance to penicillin, trimethoprim, cotrimoxazole, erythromycin, ofloxacin and ciprofloxacin, and corrected for 
population stratification using the genetic subpopulations (represented by the sequence clusters; SCs) determined 
using BAPS and/or the method proposed by Prosperi et al.62. The statistical associations were performed using 
PLINK software v1.960, and the results visualized as Manhattan and Q-Q plots in R using ‘qqman’ package.
Candidate resistance loci and a measure of the distance to resistance. We selected SNPs show-
ing statistically significant associations (p-values < 0.01 at a minor allele frequency > 0.01; Bonferroni-adjusted 
for multiple testing) as candidates for subsequent analysis. The percentage distribution of these candidate SNPs 
within resistance isolates relative to the susceptible isolates in each population was computed to determine how 
they vary in each cohort. For each SNP significantly associated with antibiotic resistance, we determined the odds 
ratio (OR) and nature (positive or negative) of the correlation. The accumulation of these significant SNPs in each 
isolate was also defined across all test cohorts. Each SNP present in an isolate was represented by the logarithmic 
derivative of the odds ratio; log10 (OR): The negative logarithmic values were used for SNPs negatively correlated 
with resistance. Q-Q plots were used to determine a more stringent p-value cut-off. The aggregate effect of the 
SNPs conferring antibiotic resistance is the sum of all the log10 (OR) values for SNPs above the p-value thresh-
old. These represented a measure of the level of resistance of an isolate. These aggregate values were plotted in 
GraphPad Prism v6.05 software.
Random forest analysis for prioritizing variants and classifying isolates. To prioritize probable 
causal variants and investigate the effect of SNPs and/or gene combinations, a Random Forest (RF) classification 
using the Bioconductor randomForest package 4.6–10 was performed. The resulting candidates were used to dis-
criminate resistant (R) and susceptible (S) isolates. This classification model, consisting of 5000 decision trees was 
trained on candidate genes and/or SNPs that were determined to be predictive of resistance through GWAS anal-
ysis. Statistical significance of the genes or SNPs that were able to discriminate between the classes were calcu-
lated by permuting the sample class labels. A normal distribution was determined for mean decrease of accuracy 
(MDA) values from the 300 feature-vector permutations using the pnorm package which is part of the R version 
3.3.0 distribution63. Still using the pnorm package, a p-value was calculated comparing the average of mda values 
for RF 100 analyses (the out-of-box - OOB - error averaged over 100 RF runs) with the original sample classes (to 
account for slight differences between RF analyses) to the distribution of permuted MDA values.
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